Deutsche Bank’s Immune Design Corp. IMDZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-176,554
| Closed | -$1.03M | – | 5744 |
|
|
2019
Q1 | $1.03M | Buy |
176,554
+132,505
| +301% | +$451K | ﹤0.01% | 2971 |
|
|
2018
Q4 | $57K | Sell |
44,049
-55,971
| -56% | -$97.3K | ﹤0.01% | 4435 |
|
|
2018
Q3 | $345K | Buy |
100,020
+36,300
| +57% | +$136K | ﹤0.01% | 3971 |
|
|
2018
Q2 | $290K | Buy |
63,720
+22,654
| +55% | +$90.2K | ﹤0.01% | 4125 |
|
|
2018
Q1 | $135K | Sell |
41,066
-31,212
| -43% | -$110K | ﹤0.01% | 4385 |
|
|
2017
Q4 | $280K | Buy |
72,278
+39,608
| +121% | +$216K | ﹤0.01% | 3868 |
|
|
2017
Q3 | $337K | Sell |
32,670
-47,610
| -59% | -$468K | ﹤0.01% | 3617 |
|
|
2017
Q2 | $782K | Buy |
80,280
+33,850
| +73% | +$238K | ﹤0.01% | 3181 |
|
|
2017
Q1 | $315K | Buy |
46,430
+37,782
| +437% | +$218K | ﹤0.01% | 3344 |
|
|
2016
Q4 | $45K | Sell |
8,648
-61,455
| -88% | -$434K | ﹤0.01% | 4383 |
|
|
2016
Q3 | $530K | Buy |
70,103
+37,239
| +113% | +$272K | ﹤0.01% | 3166 |
|
|
2016
Q2 | $267K | Sell |
32,864
-12,771
| -28% | -$159K | ﹤0.01% | 3615 |
|
|
2016
Q1 | $592K | Buy |
45,635
+6,872
| +18% | +$79.3K | ﹤0.01% | 3113 |
|
|
2015
Q4 | $777K | Buy |
38,763
+471
| +1% | +$8.12K | ﹤0.01% | 3039 |
|
|
2015
Q3 | $466K | Buy |
38,292
+35,572
| +1,308% | +$666K | ﹤0.01% | 3394 |
|
|
2015
Q2 | $56K | Buy |
2,720
+2,710
| +27,100% | +$64K | ﹤0.01% | 4536 |
|
|
2015
Q1 | $0 | Buy |
10
+7
| +233% | +$183 | ﹤0.01% | 6553 |
|
|
2014
Q4 | $0 | Sell |
3
-8,362
| -100% | -$232K | ﹤0.01% | 6626 |
|
|
2014
Q3 | $147K | Buy |
+8,365
| New | +$106K | ﹤0.01% | 4267 |
|
Deutsche Bank's IMDZ Position: Q2 2019 in Review
Deutsche Bank sold out of Immune Design Corp. (IMDZ) in Q2 2019, closing a stake of 176,554 shares — an estimated $1.03M sold.
Deutsche Bank first reported a position in IMDZ in Q3 2014 and held it in 19 quarters. The position peaked at $1.03M in Q1 2019. 0 funds tracked by Wall St. Rank hold IMDZ as of Q2 2019.
- Deutsche Bank reported no remaining Immune Design Corp. position as of Q2 2019 after selling out during the quarter.
- Deutsche Bank sold 176,554 Immune Design Corp. shares in Q2 2019, an estimated $1.03M.
- Deutsche Bank first reported a position in Immune Design Corp. in Q3 2014 and held it in 19 quarters.
- Deutsche Bank's Immune Design Corp. position peaked at $1.03M in Q1 2019.
- 0 funds tracked by Wall St. Rank held Immune Design Corp. as of Q2 2019.
Based on Deutsche Bank's 13F filing for Q2 2019, filed 14 Aug 2019.